newsfilter
← Latest News
GlobeNewswire·

Clarus Therapeutics Announces Issuance of Two New Patents for JATENZO® (testosterone undecanoate)

JATENZO is the first and only FDA-approved oral softgel for testosterone replacement therapy (TRT) in adult males who have deficient testosterone due to certain medical conditions Clarus plans to list these patents in FDA's Orange Book, which would br